Plasma tranexamic acid concentrations during cardiopulmonary bypass

Anesthesia and Analgesia
B K FiechtnerM H Ereth

Abstract

Although tranexamic acid is used to reduce bleeding after cardiac surgery, there is large variation in the recommended dose, and few studies of plasma concentrations of the drug during cardiopulmonary bypass (CPB) have been performed. The plasma tranexamic acid concentration reported to inhibit fibrinolysis in vitro is 10 microg/mL. Twenty-one patients received an initial dose of 10 mg/kg given over 20 min followed by an infusion of 1 mg. kg(-1). h(-1) via a central venous catheter. Two patients were removed from the study secondary to protocol violation. Perioperative plasma tranexamic acid concentrations were measured with high-performance liquid chromatography. Plasma tranexamic acid concentrations (microg/mL; mean +/- SD [95% confidence interval]) were 37.4 +/- 16.9 (45.5, 29.3) after bolus, 27.6 +/- 7.9 (31.4, 23.8) after 5 min on CPB, 31.4 +/- 12.1 (37.2, 25.6) after 30 min on CPB, 29.2 +/- 9.0 (34.6, 23.8) after 60 min on CPB, 25.6 +/- 18.6 (35.1, 16.1) at discontinuation of tranexamic acid infusion, and 17.7 +/- 13.1 (24.1, 11.1) 1 h after discontinuation of tranexamic acid infusion. Four patients with renal insufficiency had increased concentrations of tranexamic acid at discontinuation of the drug. Repeated-measures a...Continue Reading

References

Oct 1, 1991·American Journal of Hematology·G SoslauI Brodsky
Aug 23, 1974·European Journal of Clinical Pharmacology·O ErikssonM Schannong
Jun 28, 1968·Annals of the New York Academy of Sciences·L AnderssonB Melander
Jan 1, 1981·European Journal of Clinical Pharmacology·A PilbrantJ Vessman
Feb 1, 1995·The Annals of Thoracic Surgery·R G SpeekenbrinkL Eijsman
Feb 1, 1995·Anesthesiology·J C HorrowJ L Parmet
May 1, 1993·The American Journal of Medicine·Lawrence Tim GoodnoughH Gilbert Welch

❮ Previous
Next ❯

Citations

Aug 2, 2002·Anesthesiology·Noreen P DowdJohn Butterworth
Jan 10, 2006·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·A T L SantosI A Nesralla
Feb 2, 2010·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Dumbor L Ngaage, John Martin Bland
Jun 13, 2006·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Yves Ozier, Sylvie Schlumberger
Jul 29, 2010·Anesthesia and Analgesia·Mark A Fox
Feb 27, 2010·Anesthesia and Analgesia·Daryl L ReustFrancis G Spinale
Feb 7, 2013·Paediatric Anaesthesia·Domenico Pietrini
Sep 1, 2015·The Journal of Trauma and Acute Care Surgery·Mark E DiebelJohn R Whittaker
Aug 2, 2016·British Journal of Haematology·Krasimir Kolev, Colin Longstaff
Jul 21, 2017·Transfusion·Nicholas H SaadahMartin R Schipperus
May 31, 2019·Journal of Thrombosis and Haemostasis : JTH·James R BaylisChristian J Kastrup
Jun 19, 2004·International Anesthesiology Clinics·Andrew Maslow, Carl Schwartz
Mar 20, 2008·Anesthesia and Analgesia·Michael P Eaton
Mar 5, 2011·Haemophilia : the Official Journal of the World Federation of Hemophilia·L DaiM Mitchell
Mar 1, 2017·British Journal of Clinical Pharmacology·Ralph GertlerGunther Wiesner
May 6, 2017·Anesthesiology·Irene LeckerBeverley A Orser
Dec 2, 2017·British Journal of Clinical Pharmacology·Julien LanoiseléeUNKNOWN PeriOpeRative Tranexamic acid in hip arthrOplasty (PORTO) study investigators
Dec 5, 2017·Anesthesiology·Jerrold H LevyNigel S Key
Mar 18, 2017·Journal of Neonatal-perinatal Medicine·H K AhmadziaC A Grotegut
Feb 27, 2004·British Journal of Haematology·Brenda E S GibsonG Turner
Feb 8, 2011·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Cornelius KeylDietmar Trenk
Aug 1, 2007·Asian Cardiovascular & Thoracic Annals·Madan M Maddali, Muthukkumar C Rajakumar
Jul 26, 2014·American Journal of Veterinary Research·Daniel J FletcherBenjamin M Brainard
Dec 15, 2020·Anesthesiology·Paul Jacques ZuffereyEdouard Ollier
Jan 2, 2021·The Annals of Pharmacotherapy·Nicholas D FranzNicholas Farina
Nov 5, 2019·Advances in Anesthesia·Justin E RichardsThomas E Grissom
Jan 24, 2012·The Journal of Thoracic and Cardiovascular Surgery·Sara K PasqualiJeffrey P Jacobs

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.